$INTC Is Worth Roughly $506 Billion. External Foundry Revenue Is $293 Million. Intel rose 7.1% this week to $95.80, but the rally says more about the market’s appetite for AI-hardware optionality than new Intel proof. The number that matters is $293 million: external foundry revenue in Q2, just 1.8% of Intel’s $16.13 billion in consolidated sales. Intel Foundry reported $5.77 billion of revenue, but roughly $5.47 billion was intersegment activity eliminated on consolidation. Most of the external-revenue increase was not a fresh leading-edge win; it came from Altera becoming an external customer after deconsolidation. Foundry still lost $2.09 billion in the quarter. The moat is still prospective Intel has real assets: U.S.-based manufacturing, advanced packaging, RibbonFET, PowerVia, and decades of OEM and enterprise relationships. But TSMC’s moat is not just transistor architecture; it is yields, design tools, reliability, and customer trust built over years. Intel’s U.S. position may deserve a strategic premium, but strategic necessity reduces funding risk more readily than it guarantees attractive shareholder returns. The stock still needs one decisive proof point: a disclosed, binding, high-volume external 14A commitment alongside sustained Foundry loss compression. Data-center growth has an asterisk Data-center and AI revenue rose 59%, but server volumes increased only 9% while ASPs jumped 48%, mainly from a richer premium-product mix. That is real progress, but it says more about mix and pricing power than broad unit momentum. Meanwhile, AMD and Arm keep attacking the x86 franchise financing Intel’s transition. Cash buys time, not proof Intel ultimately issued 242.1 million shares at $95 after underwriters exercised their full option, raising about $22.62 billion net and increasing the share count roughly 4.8%. The raise meaningfully improves liquidity, but existing holders paid dilution to fund foundry economics that remain unproven. At roughly $506 billion of equity value, Intel’s pro-forma EV is about 7.1× 2027 sales, while the stock trades at 47× estimated 2027 adjusted EPS. Those are not distressed-turnaround multiples; they assume much of the turnaround works. The weekly rebound above the offering price looked more like sector beta than fresh operating validation. Bottom line Intel may become strategically indispensable, but strategic importance is not the same as shareholder economics. At this valuation, I want external 14A volume and durable Foundry loss reductions—not another internally manufactured Intel product presented as proof of third-party demand.